Patients with BRCA1/2 mutations and their families can benefit from cancer risk reduction or early cancer detection strategies, such as double mastectomy or high-risk follow-up for BC and bilateral salpingo-oophorectomy for OC (12). This evidence concerns the gene BRCA1 and cancer.